A unique “outsourced in-house” partnership model
We take a holistic approach to design and execute customized IR and PR programs for medical device, drug development, cell therapy, diagnostics and healthcare services companies.
Our Approach
Our programs are customized focusing on these four general components:
Your Story
Generating a compelling investment story that highlights your company’s growth opportunities and competitive advantages
Audience
Identifying the ideal audience(s) for your company’s story and developing audience access strategies
Relationships
Developing and managing relationships with the right sell-side “sponsors” to directly market your story to investors
BioTuesdays
Bringing your news directly to a large and targeted audience via BioTuesdays
6 REASONS
Why Kilmer Lucas
01
Healthcare-only
A strategic advisory firm with decades of industry experience.
A strategic advisory firm with decades of industry experience.
02
Unique “inside-looking-out” Orientation
The value of an IR firm with the insight of the most well-developed in-house IR department.
03
Proven Track Record
More than $3.3 billion raised to-date via multiple IPOs, follow-ons, cross-listings and uplistings.
04
BioTuesdays
Access to thousands of investment community and industry subscribers.
05
Flexibility
Round-the-clock access to senior team members.
06
Value
Reducing our clients’ cost of capital.
